Tangudu NK - Search Results

1

Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions.

Tangudu NK, Buth N, Strnad P, Cirstea IC, Spasić MV. Tangudu NK, et al. Pharmaceuticals (Basel). 2019 May 7;12(2):70. doi: 10.3390/ph12020070. Pharmaceuticals (Basel). 2019. PMID: 31067696 Free PMC article.

2

Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.

Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn AK, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vázquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J. Ahmad M, et al. Among authors: tangudu nk. Bone Res. 2022 Apr 6;10(1):33. doi: 10.1038/s41413-022-00195-z. Bone Res. 2022. PMID: 35383146 Free PMC article.

3

Despite Genetic Iron Overload, Hfe-Hemochromatosis Mice Do Not Show Bone Loss.

Wagner A, Alan B, Yilmaz D, Ahmad M, Liu P, Tangudu NK, Tuckermann JP, Vujic Spasic M. Wagner A, et al. Among authors: tangudu nk. JBMR Plus. 2019 Jul 26;3(9):e10206. doi: 10.1002/jbm4.10206. eCollection 2019 Sep. JBMR Plus. 2019. PMID: 31667458 Free PMC article.

4

Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model.

Tangudu NK, Alan B, Vinchi F, Wörle K, Lai D, Vettorazzi S, Leopold K, Vujić Spasić M. Tangudu NK, et al. Antioxid Redox Signal. 2018 Aug 10;29(5):484-499. doi: 10.1089/ars.2017.7089. Epub 2018 Mar 2. Antioxid Redox Signal. 2018. PMID: 29212341 Free PMC article.

5

Macrophage-HFE controls iron metabolism and immune responses in aged mice.

Tangudu NK, Yilmaz D, Wörle K, Gruber A, Colucci S, Leopold K, Muckenthaler MU, Vujic Spasic M. Tangudu NK, et al. Haematologica. 2021 Jan 1;106(1):259-263. doi: 10.3324/haematol.2019.235630. Haematologica. 2021. PMID: 32079697 Free PMC article. No abstract available.

6

Biodrug Suppresses Breast and Colorectal Cancer in Murine Models.

Beevi SS, Tangudu NK, Verma VK, Dinesh Kumar L. Beevi SS, et al. Among authors: tangudu nk. Methods Mol Biol. 2019;1974:245-263. doi: 10.1007/978-1-4939-9220-1_19. Methods Mol Biol. 2019. PMID: 31099009

7

53BP1: guarding the genome with a novel liquid weapon.

Tangudu NK, Aird KM. Tangudu NK, et al. Commun Biol. 2022 May 10;5(1):435. doi: 10.1038/s42003-022-03401-0. Commun Biol. 2022. PMID: 35538213 Free PMC article.

8

Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models.

Kumar A, Singam A, Swaminathan G, Killi N, Tangudu NK, Jose J, Gundloori Vn R, Dinesh Kumar L. Kumar A, et al. Among authors: tangudu nk. Nanoscale. 2022 Jan 6;14(2):492-505. doi: 10.1039/d1nr04411g. Nanoscale. 2022. PMID: 34913453

9

RNA Interference Using c-Myc-Conjugated Nanoparticles Suppresses Breast and Colorectal Cancer Models.

Tangudu NK, Verma VK, Clemons TD, Beevi SS, Hay T, Mahidhara G, Raja M, Nair RA, Alexander LE, Patel AB, Jose J, Smith NM, Zdyrko B, Bourdoncle A, Luzinov I, Iyer KS, Clarke AR, Dinesh Kumar L. Tangudu NK, et al. Mol Cancer Ther. 2015 May;14(5):1259-69. doi: 10.1158/1535-7163.MCT-14-0970. Epub 2015 Feb 18. Mol Cancer Ther. 2015. PMID: 25695957 Free article.

10

DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A.

Leon KE, Buj R, Lesko E, Dahl ES, Chen CW, Tangudu NK, Imamura-Kawasawa Y, Kossenkov AV, Hobbs RP, Aird KM. Leon KE, et al. Among authors: tangudu nk. J Cell Biol. 2021 Aug 2;220(8):e202008101. doi: 10.1083/jcb.202008101. Epub 2021 May 26. J Cell Biol. 2021. PMID: 34037658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page